AQR Capital Management LLC decreased its stake in shares of MEDNAX Inc (NYSE:MD) by 53.8% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 261,273 shares of the company’s stock after selling 304,005 shares during the quarter. AQR Capital Management LLC owned about 0.31% of MEDNAX worth $3,041,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently made changes to their positions in the company. Starboard Value LP grew its position in MEDNAX by 103.4% in the 1st quarter. Starboard Value LP now owns 7,890,000 shares of the company’s stock valued at $91,840,000 after purchasing an additional 4,010,000 shares during the period. ArrowMark Colorado Holdings LLC lifted its stake in MEDNAX by 55.5% during the 1st quarter. ArrowMark Colorado Holdings LLC now owns 8,322,322 shares of the company’s stock valued at $96,872,000 after acquiring an additional 2,969,803 shares in the last quarter. P2 Capital Partners LLC lifted its stake in MEDNAX by 41.8% during the 4th quarter. P2 Capital Partners LLC now owns 3,900,025 shares of the company’s stock valued at $108,382,000 after acquiring an additional 1,150,025 shares in the last quarter. Norges Bank bought a new position in MEDNAX during the 4th quarter valued at $28,748,000. Finally, Silver Rock Financial LP bought a new position in MEDNAX during the 1st quarter valued at $3,291,000. 96.38% of the stock is owned by institutional investors.
MD stock opened at $17.10 on Wednesday. The company has a quick ratio of 2.72, a current ratio of 2.72 and a debt-to-equity ratio of 1.46. The firm has a market capitalization of $1.40 billion, a PE ratio of -1.11, a PEG ratio of 1.06 and a beta of 1.42. MEDNAX Inc has a twelve month low of $7.37 and a twelve month high of $28.66. The stock has a 50-day simple moving average of $16.31 and a two-hundred day simple moving average of $18.89.
MEDNAX (NYSE:MD) last posted its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.52 by ($0.20). MEDNAX had a negative net margin of 36.30% and a positive return on equity of 12.72%. The company had revenue of $846.00 million for the quarter, compared to analysts’ expectations of $850.88 million. During the same period in the previous year, the firm earned $0.71 EPS. The firm’s quarterly revenue was down .6% compared to the same quarter last year. On average, equities research analysts anticipate that MEDNAX Inc will post 1.55 EPS for the current fiscal year.
Several equities analysts have weighed in on MD shares. Robert W. Baird dropped their price objective on MEDNAX from $21.00 to $16.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 21st. Credit Suisse Group lifted their target price on MEDNAX from $20.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. ValuEngine upgraded MEDNAX from a “strong sell” rating to a “sell” rating in a research note on Saturday, June 13th. Zacks Investment Research upgraded MEDNAX from a “sell” rating to a “hold” rating and set a $12.00 target price on the stock in a research note on Wednesday, April 8th. Finally, BMO Capital Markets boosted their price objective on MEDNAX from $16.00 to $20.00 in a research note on Monday, June 8th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company’s stock. MEDNAX presently has a consensus rating of “Hold” and a consensus target price of $18.62.
MEDNAX Company Profile
MEDNAX, Inc, together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services.
Featured Article: What are different types of coverage ratios?
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MEDNAX Inc (NYSE:MD).
Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.